ARG24140

anti-8 Hydroxyguanosine (8-OHdG) antibody [15A3] (Biotin)

anti-8 Hydroxyguanosine (8-OHdG) antibody [15A3] (Biotin) for Dot blot,ELISA,ICC/IF,IHC-Frozen sections,IHC-Formalin-fixed paraffin-embedded sections and Other

概述

产品描述 Biotin-conjugated Mouse Monoclonal antibody [15A3] recognizes 8 Hydroxyguanosine (8-OHdG)
反应物种 Other
应用 Dot, ELISA, ICC/IF, IHC-Fr, IHC-P
特异性 Recognizes markers of oxidative damage to DNA (8- hydroxy-2' -deoxyguanosine, 8- hydroxyguanine and 8- hydroxyguanosine)
宿主 Mouse
克隆 Monoclonal
克隆号 15A3
同位型 IgG2b
靶点名称 8 Hydroxyguanosine (8-OHdG)
抗原 8-hydroxy-guanosine-BSA and -casein conjugates
偶联标记 Biotin
別名 8-Hydroxy Guanine; 8-OH-dG; 8OHG; 80G; 8 hydroxyguanine; 8 hydroxy 2' deoxyguanosine; 8 hydroxyguanosine; 8 OHG; 8-OHG; 8OHdG

应用说明

应用建议
应用 推荐稀释比
DotAssay-dependent
ELISAAssay-dependent
ICC/IFAssay-dependent
IHC-Fr1:1000
IHC-P1:1000
应用说明 * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

属性

形式 Liquid
纯化 Purification with Protein G.
缓冲液 PBS, 0.1% Sodium azide and 50% Glycerol
抗菌剂 0.1% Sodium azide
稳定剂 50% Glycerol
浓度 1 mg/ml
存放说明 For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
注意事项 For laboratory research only, not for drug, diagnostic or other use.

生物信息

背景介绍 8-hydroxyguanine, 8-hydroxy-2’-deoxyguanonsine and 8- hydroxyguanosine are all RNA and DNA markers of oxidative damage. 8-hydroxy-2’-guanosine is produced by reactive oxygen and nitrogen species including hydroxyl radical and peroxynitrite. Specifically its high biological relevance is due to its ability to induce G to T transversions, which is one of the most frequent somatic mutations
产品亮点 Related products:
anti-8 Hydroxyguanosine (8-OHdG) antibody [15A3]
Related news:
Pericytes, new therapeutic target for Alzheimer's disease?